Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

March 27 2023 - Novartis' Kisqali cuts recurrence risk in early-stage breast cancer

Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novo's high-dose Rybelsus win tees up regulatory filings
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
BrainStorm secures FDA adcomm for ALS therapy NurOwn
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings

Neurotechnology company Cognito Therapeutics scores $73M to study Alzheimer's device

Mobihealthnews

Thursday, March 23, 2023 - 9:19pm

tags:

Cognito Therapeutics, Alzheimer's disease, Medtech, funding, neuromodulation

Medtronic merges robotic, legacy surgery businesses into one unit

Medtech Dive

Thursday, March 23, 2023 - 9:14pm

tags:

Medtronic, Medtech, robotic surgery, surgery

Genentech turns out lights at first commercial biologics plant, laying off 265 staffers

Fierce Pharma

Thursday, March 23, 2023 - 9:10pm

tags:

Genentech, Roche, biologics, San Francisco, California, layoffs

Biohaven strikes a deal to take TYK2 drugs in a new direction

BioPharma Dive

Thursday, March 23, 2023 - 9:05pm

tags:

Biohaven, Pfizer, Hangzhou Highlightll, psoriasis

Secura Bio to keep offering blood cancer drug despite negative ODAC vote, OS questions

Endpoints

Thursday, March 23, 2023 - 8:59pm

tags:

Secura Bio, Copiktra, CLL, small lymphocytic lymphoma, FDA

Takeda invests $760M+ into new plasma-derived therapy manufacturing site in Japan

Endpoints

Thursday, March 23, 2023 - 8:54pm

tags:

Takeda, Japan, plasma therapy, drug manufacturing

FDA approves new antifungal as concerns grow over drug-resistant fungus

BioPharma Dive

Thursday, March 23, 2023 - 8:53pm

tags:

FDA, Cidara Therapeutics, Melinta Therapeutics, antifungals, candidemia, candidiasis, Rezzayo

Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio collab

Fierce Biotech

Thursday, March 23, 2023 - 11:53am

tags:

Moderna Therapeutics, gene therapy, Generation Bio

Disgraced former Seagen CEO tapped to lead MorphImmune less than a year after domestic assault arrest

Fierce Biotech

Thursday, March 23, 2023 - 11:51am

tags:

Seagen, MorphImmunce, Pharma CEOs, Purdue University, Clay Siegall

Royalty Pharma hands off $100M upfront for PureTech royalty on Karuna's schizophrenia hopeful

Endpoints

Thursday, March 23, 2023 - 11:49am

tags:

Royalty Pharma, Karuna Therapeutics, KarXT, schizophrenia, PureTech

Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD

Fierce Pharma

Thursday, March 23, 2023 - 11:44am

tags:

Sanofi, Regeneron, Dupixent, COPD, clinical trials

Visus concludes subject enrolment in presbyopia therapy trial

Clinical Trials Arena

Thursday, March 23, 2023 - 11:42am

tags:

Visus Therapeutics, clinical trials, presbyopia, Brimochol

Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series

Drugs.com

Thursday, March 23, 2023 - 11:41am

tags:

Astellas, zolbetuximab, clinical trials, gastric cancer

AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda

Fierce Pharma

Thursday, March 23, 2023 - 11:39am

tags:

AbbVie, Skyrizi, IBD, ulcerative colitis, clinical trials

Exploring the potential of the metaverse in healthcare

Pharmaphorum

Thursday, March 23, 2023 - 11:36am

tags:

metaverse, Healthcare, consumers

Will Eli Lilly Be a Trillion-Dollar Stock by 2030?

Motley Fool

Thursday, March 23, 2023 - 11:35am

tags:

Eli Lilly, Mounjaro

‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate

Biopharma Reporter

Thursday, March 23, 2023 - 11:11am

tags:

biotech, UK, innovation, R&D

Ionis Rockets As Biogen-Partnered ALS Drug Wins Key Endorsement

Investors Business Daily

Thursday, March 23, 2023 - 9:58am

tags:

Ionis Pharmaceuticals, Biogen, ALS, FDA, tofersen

89Bio Enlivened by Nash success

EP Vantage

Thursday, March 23, 2023 - 9:50am

tags:

89Bio, NASH, Akero Therapeutics, pegozafermin, INTERCEPT, Madrigal Pharmaceuticals

In a surprise approval, FDA green-lights Incyte's PD-1 inhibitor to treat rare cancer type

Fierce Pharma

Wednesday, March 22, 2023 - 9:27pm

tags:

Incyte, Zynyz, FDA, Merkel cell carcinoma

Pages

Latest CP Wire Articles

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

Korean firm LG Chem buying AVEO Oncology for $566M

Latest Pharmagather Articles

Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)

Drug Channels

Winning the Race for Patient Access: Identifying Copay Accumulator Impact

Drug Channels

Gene Drives Are Coming

In the Pipeline

Organizing Our Thoughts About Cells - Finally

In the Pipeline

Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists

Drug Channels

The Right Assay With the Right Cells

In the Pipeline

Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress

Drug Channels

Peptide-Encoded Screening Libraries

In the Pipeline

It's Not All Bad News: Data Shows There's a Collaborative Future for 340B

Drug Channels